Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment

N/ANot Yet RecruitingNCT07191496

M.D. Anderson Cancer Center50 enrolled

Overview

To assess the quality of life for women who were pregnant during their breast cancer treatment.

Primary Objectives Provide preliminary data to describe the current QOL of breast cancer survivors who received cancer treatment while pregnant. Secondary Objectives Identify the relationship between QOL and anxiety, depression, fear of cancer recurrence, and social support in breast cancer survivors, who received treatment while pregnant.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Breast Cancer Survivor Pregnant Women Quality of Lifte

Interventions

QuestionnaireOTHER

The questionnaires include the Ferrans and Powers QLI, EORTC QLQ-C30, FCR-7 Scale, HADS, and MOS Social Support Survey.

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Eligibility Criteria * Female, any current age and any age at diagnosis * Documented diagnosis of breast cancer during pregnancy * Documentation of receiving chemotherapy during pregnancy * Alive with no evidence of disease at time of recruitment * Able to reach and speak English Exclusion Criteria * Any woman who delayed and received their chemotherapy after delivery. * Any woman who was diagnosed with breast cancer before or after their pregnancy. * Any woman whom there is documentation of inability to provide consent in the medical record

Locations (1)

MD Anderson Cancer Center

Houston, Texas, United States

Outcomes

Primary Outcomes

QOL Questionnaires

Time frame: Through study completion; an average of 1 year

Central Contacts

Eileen Hacker, MD

CONTACT

Hacker ehacker@mdanderson.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.